SK283471B6 - Spôsob prípravy enantiomérne čistých imidazolylových zlúčenín, imidazolylové zlúčeniny - Google Patents
Spôsob prípravy enantiomérne čistých imidazolylových zlúčenín, imidazolylové zlúčeniny Download PDFInfo
- Publication number
- SK283471B6 SK283471B6 SK1287-96A SK128796A SK283471B6 SK 283471 B6 SK283471 B6 SK 283471B6 SK 128796 A SK128796 A SK 128796A SK 283471 B6 SK283471 B6 SK 283471B6
- Authority
- SK
- Slovakia
- Prior art keywords
- acid
- addition salt
- compound
- acid addition
- formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/06—Peri-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Epoxy Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP95202765 | 1995-10-13 |
Publications (2)
Publication Number | Publication Date |
---|---|
SK128796A3 SK128796A3 (en) | 1997-05-07 |
SK283471B6 true SK283471B6 (sk) | 2003-08-05 |
Family
ID=8220714
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SK1287-96A SK283471B6 (sk) | 1995-10-13 | 1996-10-08 | Spôsob prípravy enantiomérne čistých imidazolylových zlúčenín, imidazolylové zlúčeniny |
Country Status (24)
Country | Link |
---|---|
US (1) | US5663343A (es) |
EP (1) | EP0768309B1 (es) |
JP (2) | JP4590038B2 (es) |
KR (1) | KR100459745B1 (es) |
CN (1) | CN1060774C (es) |
AT (1) | ATE224896T1 (es) |
AU (1) | AU702594B2 (es) |
CA (1) | CA2187484C (es) |
CZ (1) | CZ288042B6 (es) |
DE (1) | DE69623900T2 (es) |
DK (1) | DK0768309T3 (es) |
DZ (1) | DZ2104A1 (es) |
ES (1) | ES2183908T3 (es) |
HK (1) | HK1000446A1 (es) |
HU (1) | HU226620B1 (es) |
IL (1) | IL119400A (es) |
NO (1) | NO307257B1 (es) |
NZ (1) | NZ299562A (es) |
PT (1) | PT768309E (es) |
RU (1) | RU2162085C2 (es) |
SK (1) | SK283471B6 (es) |
TW (1) | TW513423B (es) |
UA (1) | UA48947C2 (es) |
ZA (1) | ZA968525B (es) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19813661A1 (de) * | 1997-08-01 | 1999-02-04 | Solvay Pharm Gmbh | Gegen Racemisierung stabilisierte pharmazeutische Zubereitungen von Cilansetron |
US6372919B1 (en) * | 2001-01-11 | 2002-04-16 | Dov Pharmaceutical, Inc. | (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as an anti-depressant agent |
US20040048874A1 (en) * | 2001-05-22 | 2004-03-11 | Bardsley Hazel Judith | New therapeutic use of 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno[2,3-D]pyrimidine |
GB0216027D0 (en) * | 2002-07-10 | 2002-08-21 | Arachnova Therapeutics Ltd | New therapeutic use |
US7015333B2 (en) * | 2002-11-18 | 2006-03-21 | Solvay Pharmaceuticals B.V. | Process for preparation of imidazolyl compounds |
EP1424337A1 (en) * | 2002-11-26 | 2004-06-02 | Solvay Pharmaceuticals GmbH | 4-hydroxy derivatives of 5,6,9,10-tetrahydro-10-((2-methyl-1h-imidazol-1-yl)methyl)-4h-pyrido-(3,2,1-jk)-carbazol-11(8h)-one |
AU2004204825B2 (en) * | 2003-01-13 | 2007-07-19 | Dynogen Pharmaceuticals, Inc. | Method of treating functional bowel disorders |
PL378369A1 (pl) * | 2003-01-13 | 2006-04-03 | Dynogen Pharmaceuticals, Inc. | Sposób leczenia mdłości, wymiotów, nudności lub ich dowolnej kombinacji |
AU2004227945B2 (en) * | 2003-04-04 | 2006-10-26 | Dynogen Pharmaceuticals, Inc. | Method of treating lower urinary tract disorders |
EP1706394B1 (en) * | 2003-11-12 | 2014-12-17 | Dr. Reddy's Laboratories, Inc. | Preparation of escitalopram |
US20070043100A1 (en) | 2005-08-16 | 2007-02-22 | Hagen Eric J | Novel polymorphs of azabicyclohexane |
US20080045725A1 (en) | 2006-04-28 | 2008-02-21 | Murry Jerry A | Process For The Synthesis of (+) And (-)-1-(3,4-Dichlorophenyl)-3-Azabicyclo[3.1.0]Hexane |
US7662831B2 (en) | 2006-07-27 | 2010-02-16 | Wyeth Llc | Tetracyclic indoles as potassium channel modulators |
US7601856B2 (en) | 2006-07-27 | 2009-10-13 | Wyeth | Benzofurans as potassium ion channel modulators |
JP5156222B2 (ja) * | 2006-11-28 | 2013-03-06 | エムキュア ファーマシューティカルズ リミテッド | 制吐作用化合物の新たな製造方法 |
GB0910373D0 (en) * | 2009-06-16 | 2009-07-29 | Filtrona Int Ltd | Tabacco smoke filter |
US9806720B1 (en) * | 2016-10-07 | 2017-10-31 | Analog Devices Global | Compound semiconductor based inverter |
WO2019222565A1 (en) * | 2018-05-18 | 2019-11-21 | Kura Oncology, Inc. | Synthesis of tipifarnib |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL7413843A (nl) * | 1974-10-23 | 1976-04-27 | Stamicarbon | Optische scheiding van fenylglycine-amide. |
US4849527A (en) * | 1982-09-13 | 1989-07-18 | Bristol-Myers Company | Process for resolution of optical isomers |
US4463176A (en) * | 1982-09-13 | 1984-07-31 | Mead Johnson & Company | Process for resolution of optical isomers |
CH664152A5 (fr) * | 1984-01-25 | 1988-02-15 | Glaxo Group Ltd | Derives de tetrahydrocarbazolones. |
ES2059491T3 (es) * | 1987-06-29 | 1994-11-16 | Duphar Int Res | Derivados de indol con anillos condensados. |
GB8812636D0 (en) * | 1988-05-27 | 1988-06-29 | Glaxo Group Ltd | Chemical compounds |
EP0350129A1 (en) * | 1988-07-07 | 1990-01-10 | Duphar International Research B.V | New annelated indoleketones with an imidazolylalkyl substituent |
DE4238553A1 (de) * | 1992-11-14 | 1994-05-19 | Kali Chemie Pharma Gmbh | Neue Imidazol-1-yl-Verbindungen enthaltende Arzneimittel |
-
1996
- 1996-09-26 AU AU65856/96A patent/AU702594B2/en not_active Ceased
- 1996-10-03 TW TW085112098A patent/TW513423B/zh not_active IP Right Cessation
- 1996-10-08 SK SK1287-96A patent/SK283471B6/sk not_active IP Right Cessation
- 1996-10-08 JP JP28461296A patent/JP4590038B2/ja not_active Expired - Fee Related
- 1996-10-08 CZ CZ19962947A patent/CZ288042B6/cs not_active IP Right Cessation
- 1996-10-09 NO NO964282A patent/NO307257B1/no not_active IP Right Cessation
- 1996-10-09 HU HU9602778A patent/HU226620B1/hu not_active IP Right Cessation
- 1996-10-09 DZ DZ960148A patent/DZ2104A1/fr active
- 1996-10-09 RU RU96120366/04A patent/RU2162085C2/ru not_active IP Right Cessation
- 1996-10-09 CA CA002187484A patent/CA2187484C/en not_active Expired - Fee Related
- 1996-10-09 ZA ZA968525A patent/ZA968525B/xx unknown
- 1996-10-10 IL IL11940096A patent/IL119400A/xx not_active IP Right Cessation
- 1996-10-10 US US08/728,794 patent/US5663343A/en not_active Expired - Lifetime
- 1996-10-10 EP EP96202829A patent/EP0768309B1/en not_active Expired - Lifetime
- 1996-10-10 ES ES96202829T patent/ES2183908T3/es not_active Expired - Lifetime
- 1996-10-10 AT AT96202829T patent/ATE224896T1/de active
- 1996-10-10 DE DE69623900T patent/DE69623900T2/de not_active Expired - Lifetime
- 1996-10-10 UA UA96103876A patent/UA48947C2/uk unknown
- 1996-10-10 PT PT96202829T patent/PT768309E/pt unknown
- 1996-10-10 CN CN96122637A patent/CN1060774C/zh not_active Expired - Fee Related
- 1996-10-10 DK DK96202829T patent/DK0768309T3/da active
- 1996-10-10 KR KR1019960044972A patent/KR100459745B1/ko not_active IP Right Cessation
- 1996-10-11 NZ NZ299562A patent/NZ299562A/en not_active IP Right Cessation
-
1997
- 1997-07-19 HK HK97101586A patent/HK1000446A1/xx not_active IP Right Cessation
-
2010
- 2010-04-15 JP JP2010094211A patent/JP2010159292A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SK283471B6 (sk) | Spôsob prípravy enantiomérne čistých imidazolylových zlúčenín, imidazolylové zlúčeniny | |
US7550479B2 (en) | Modified Pictet-Spengler reaction and products prepared therefrom | |
US8846954B2 (en) | Crystallisation and purification of glycopyrronium bromide | |
FR2671800A1 (fr) | Derive de la 5h-pyrrolo[3,4-b]pyrazine optiquement actif, sa preparation et les compositions pharmaceutiques qui le contiennent. | |
FR2553777A1 (fr) | Nouveaux complexes de platine et leur application en therapeutique | |
CZ294964B6 (cs) | Způsob přípravy (-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)fenyl]hydrazon]propandinitrilu s optickou čistotou nad 90 % | |
FR2688506A1 (fr) | Procede de preparation de sels de l'acide clavulanique. | |
RU2276152C1 (ru) | R-(-)-1-[2-(7-ХЛОРБЕНЗО[b]ТИОФЕН-3-ИЛМЕТОКСИ)-2-(2,4-ДИХЛОРФЕНИЛ)ЭТИЛ]-1H-ИМИДАЗОЛ И ЕГО СОЛИ, СПОСОБ ИХ ПОЛУЧЕНИЯ, КОМПОЗИЦИЯ, ОБЛАДАЮЩАЯ ПРОТИВОГРИБКОВЫМ ДЕЙСТВИЕМ | |
US8461334B2 (en) | Process for resolving zopiclone | |
US20210188767A1 (en) | Method for the purification of cysteamine | |
US20080255371A1 (en) | Method for improving optical purity of 1-benzyl-3-aminopyrolidine and salt for use therein | |
US6521792B2 (en) | Process for separating the diastereomeric bases of 2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)-cylohexanol | |
EP0784608B1 (en) | The manufacture of levobupivacaine and analogues thereof from l-lysine | |
US20090264662A1 (en) | PROCESS FOR THE PREPARATION OF 5,6 -DIHYDRO -4H-4(S)-ETHYLAMINO-6(S)-METHYLTHIENO[2,3-b] THIOPYRAN-2-SULFONAMIDE- 7,7 -DIOXIDE AND ITS SALT | |
US6365743B1 (en) | Process for the preparation of enantiomerically pure imidazolyl compounds | |
BG100218A (bg) | Енантиомери на 4-(5-флуоро-2,3-дихидро-1н-инден-2-ил)- 1н-имидазол | |
MXPA96004670A (es) | Procedimiento para la preparacion de compuestos de imidazolilo enantiomericamente puros | |
CA2201779C (en) | The manufacture of levobupivacaine and analogues thereof from l-lysine | |
US20040087569A1 (en) | N-heterocyclic bicyclic lactone compounds | |
FR2466249A1 (fr) | Composition therapeutique pour reduire la pression intraoculaire de l'oeil humain, procede de preparation de cette composition et application au traitement du glaucome | |
JPH10101626A (ja) | 高純度光学活性アミノ酸またはその塩酸塩の製造法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Patent lapsed due to non-payment of maintenance fees |
Effective date: 20111008 |